HIV treatment pause study tests antibody cocktail plus immune booster
NCT ID NCT05245292
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tested whether a combination of two long-acting antibodies (3BNC117-LS and 10-1074-LS) plus an immune-boosting drug (N-803) can safely control HIV in people who temporarily stop their regular antiretroviral therapy. 28 adults with well-controlled HIV took part. The goal was to see if the treatment could delay or prevent the virus from rebounding without needing daily pills.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HUMAN IMMUNODEFICIENCY VIRUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Perelman School of Medicine University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
-
The Rockefeller University
New York, New York, 10065, United States
-
Weill Cornell Medicine, Cornell Clinical Trials Unit
New York, New York, 10021, United States
Conditions
Explore the condition pages connected to this study.